These are all the companies that Avecia has acquired. Avecia's latest acquisition was Avrio Biopharmaceuticals in Oct 2016. Avrio Biopharmaceuticals offers formulation development, parenteral manufacturing, lyophilization and regulatory filing support services.
No recent investments found related to Avecia
Milford Facility Location 125 Fortune Boulevard
1-508-532-2500Driving Directions »